Reference ranges for complete blood count in children and adolescents with Down syndrome

Martina Lattuada1, Giulia Capitoli2,3, Marco Casati4

  • 1School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Frontiers in Pediatrics
|December 26, 2024
PubMed

Insights

New reference ranges for complete blood counts (CBCs) in Down syndrome (DS) patients show significant differences compared to the general population. These findings aid in accurate interpretation of CBC results for individuals with DS.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Down syndrome (DS) is associated with distinct hematopoietic features impacting complete blood count (CBC) parameters.
  • Establishing accurate, population-specific reference ranges is critical for effective CBC interpretation in individuals with DS.

Purpose of the Study:

  • To develop age- and sex-specific reference ranges for CBC parameters in patients with Down syndrome.
  • To create a tool for clinicians to compare individual CBC results against these new reference ranges.

Main Methods:

  • A retrospective analysis of 2,627 CBCs from 481 Down syndrome patients (aged 31 days to 18 years) was conducted.
  • Patients with significant comorbidities were excluded to ensure a homogeneous study group.
  • Centile charts were generated for each CBC parameter.

Main Results:

  • Significant differences were observed in hemoglobin, hematocrit, and mean corpuscular volume, which were higher in the DS cohort compared to the general pediatric population (p < 0.001).
  • A notable percentage of DS patients exhibited white blood cell counts below the 2.5th centile of healthy controls (p < 0.001), with exceptions in the youngest age group.
  • Lymphocyte counts also showed a similar trend in older DS patients (p < 0.001).

Conclusions:

  • The newly established DS-specific CBC reference ranges serve as a vital clinical tool for accurate interpretation.
  • These ranges can potentially minimize unnecessary diagnostic tests and underscore the importance of tailored clinical management for individuals with Down syndrome.
Abstract